168 related articles for article (PubMed ID: 29344738)
21. Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR.
Yang T; Esteve E; Pessah IN; Molinski TF; Allen PD; López JR
Am J Physiol Cell Physiol; 2007 May; 292(5):C1591-8. PubMed ID: 17182726
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling.
Weiss RG; O'Connell KM; Flucher BE; Allen PD; Grabner M; Dirksen RT
Am J Physiol Cell Physiol; 2004 Oct; 287(4):C1094-102. PubMed ID: 15201141
[TBL] [Abstract][Full Text] [Related]
23. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
[TBL] [Abstract][Full Text] [Related]
24. Functional characterization of 2 known ryanodine receptor mutations causing malignant hyperthermia.
Schiemann AH; Paul N; Parker R; Pollock N; Bulger TF; Stowell KM
Anesth Analg; 2014 Feb; 118(2):375-380. PubMed ID: 24361844
[TBL] [Abstract][Full Text] [Related]
25. Effects of Remimazolam and Propofol on Ca
Watanabe T; Miyoshi H; Noda Y; Narasaki S; Morio A; Toyota Y; Kimura H; Mukaida K; Yasuda T; Tsutsumi YM
Biomed Res Int; 2021; 2021():8845129. PubMed ID: 33490280
[TBL] [Abstract][Full Text] [Related]
26. Assessing the pathogenicity of RYR1 variants in malignant hyperthermia.
Merritt A; Booms P; Shaw MA; Miller DM; Daly C; Bilmen JG; Stowell KM; Allen PD; Steele DS; Hopkins PM
Br J Anaesth; 2017 Apr; 118(4):533-543. PubMed ID: 28403410
[TBL] [Abstract][Full Text] [Related]
27. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
[TBL] [Abstract][Full Text] [Related]
28. Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.
Loke JC; Kraev N; Sharma P; Du G; Patel L; Kraev A; MacLennan DH
Anesthesiology; 2003 Aug; 99(2):297-302. PubMed ID: 12883402
[TBL] [Abstract][Full Text] [Related]
29. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
[TBL] [Abstract][Full Text] [Related]
30. Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.
Sei Y; Brandom BW; Bina S; Hosoi E; Gallagher KL; Wyre HW; Pudimat PA; Holman SJ; Venzon DJ; Daly JW; Muldoon S
Anesthesiology; 2002 Nov; 97(5):1052-8. PubMed ID: 12411786
[TBL] [Abstract][Full Text] [Related]
31. Functional analysis of newly identified RYR1 variants in patients susceptible to malignant hyperthermia.
Noda Y; Yasuda T; Kanzaki R; Miyoshi H; Mukaida K; Kamiya S; Morio A; Hamada H; Kawamoto M; Tsutsumi YM
J Anesth; 2020 Oct; 34(5):658-665. PubMed ID: 32535660
[TBL] [Abstract][Full Text] [Related]
32. Increasing the number of diagnostic mutations in malignant hyperthermia.
Levano S; Vukcevic M; Singer M; Matter A; Treves S; Urwyler A; Girard T
Hum Mutat; 2009 Apr; 30(4):590-8. PubMed ID: 19191329
[TBL] [Abstract][Full Text] [Related]
33. Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.
McKinney LC; Butler T; Mullen SP; Klein MG
Anesthesiology; 2006 Jun; 104(6):1191-201. PubMed ID: 16732090
[TBL] [Abstract][Full Text] [Related]
34. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
Ta TA; Pessah IN
Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
[TBL] [Abstract][Full Text] [Related]
35. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
36. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse.
Yang T; Riehl J; Esteve E; Matthaei KI; Goth S; Allen PD; Pessah IN; Lopez JR
Anesthesiology; 2006 Dec; 105(6):1164-75. PubMed ID: 17122579
[TBL] [Abstract][Full Text] [Related]
38. Preclinical model systems of ryanodine receptor 1-related myopathies and malignant hyperthermia: a comprehensive scoping review of works published 1990-2019.
Lawal TA; Wires ES; Terry NL; Dowling JJ; Todd JJ
Orphanet J Rare Dis; 2020 May; 15(1):113. PubMed ID: 32381029
[TBL] [Abstract][Full Text] [Related]
39. Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations.
Rueffert H; Olthoff D; Deutrich C; Meinecke CD; Froster UG
Acta Anaesthesiol Scand; 2002 Jul; 46(6):692-8. PubMed ID: 12059893
[TBL] [Abstract][Full Text] [Related]
40. Malignant hyperthermia causing Gly2435Arg mutation of the ryanodine receptor facilitates ryanodine-induced calcium release in myotubes.
Brinkmeier H; Krämer J; Krämer R; Iaizzo PA; Baur C; Lehmann-Horn F; Rüdel R
Br J Anaesth; 1999 Dec; 83(6):855-61. PubMed ID: 10700782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]